电邮这篇文章 Fulminant diabetes mellitus and concomitant enterovirus infection: a clinical case
- 作者: Saprina T.V.1, Musina N.N.1, Vtorushin S.V.1,2, Krakhmal’ N.V.1,2, Rogovskaya Y.V.3
-
隶属关系:
- Siberian State Medical University
- Cancer Research Institute, Tomsk National Research Medical Center
- Cardiology Research Institute, Tomsk National Research Medical Center
- 期: 卷 26, 编号 2 (2020)
- 页面: 125-132
- 栏目: Case reports
- URL: https://journal-vniispk.ru/0869-2106/article/view/42556
- DOI: https://doi.org/10.18821/0869-2106-2020-26-2-125-132
- ID: 42556
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Fulminant type 1 diabetes mellitus is a subtype of diabetes mellitus. It is characterized by the extremely rapid development of hyperglycemia and ketoacidosis because of the near-total destruction of pancreatic β-cells. A clinical case of lethal, type 1, fulminant diabetes mellitus is presented. The patient management strategy and possible causes of the adverse course and outcome of the disease are analyzed.
作者简介
T. Saprina
Siberian State Medical University
编辑信件的主要联系方式.
Email: tvsaprina@gmail.com
ORCID iD: 0000-0001-9011-8720
MD, PhD, DSc, Professor
俄罗斯联邦, TomskN. Musina
Siberian State Medical University
Email: nadiezhda-musina@mail.ru
ORCID iD: 0000-0001-7148-6739
俄罗斯联邦, Tomsk
S. Vtorushin
Siberian State Medical University; Cancer Research Institute, Tomsk National Research Medical Center
Email: wtorushin@rambler.ru
ORCID iD: 0000-0002-1195-4008
MD, PhD, DSc, Professor
俄罗斯联邦, TomskN. Krakhmal’
Siberian State Medical University; Cancer Research Institute, Tomsk National Research Medical Center
Email: krakhmal@mail.ru
ORCID iD: 0000-0002-1909-1681
MD, PhD
俄罗斯联邦, TomskYu. Rogovskaya
Cardiology Research Institute, Tomsk National Research Medical Center
Email: mynga@sibmail.com
ORCID iD: 0000-0001-5553-7831
MD, PhD
俄罗斯联邦, Tomsk参考
- Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N. Engl. J. Med. 2000; 342(5): 301–7. doi: 10.1056/NEJM200002033420501.
- Moreau C., Drui D., Arnault-Ouary G., Charbonnel B., Chaillous L., Cariou B. Fulminant type 1 diabetes in Caucasians: a report of three cases. Diabetes Metab. 2008; 34(5): 529–32. doi: 10.1016/j.diabet.2008.05.003.
- Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T. et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003; 26(8): 2345–52. doi: 10.2337/diacare.26.8.2345.
- Imagawa A., Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud. 2006; 3(4): 169–77. doi: 10.1900/RDS.2006.3.169.
- Imagawa A., Hanafusa T., Makino H., Miyagawa J.I., Juto P. High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia. 2005 Feb; 48(2): 290–3. doi: 10.1007/s00125-004-1624-z.
- Tanaka S., Nishida Y., Aida K., Maruyama T., Shimada A., Suzuki M. et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009; 58(10): 2285–91. doi: 10.2337/db09-0091.
- Imagawa A., Hanafusa T., Awata T., Ikegami H., Uchigata Y., Osawa H. et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). Diabetes Investig. 2012; 3(6): 536–9. doi: 10.1111/jdi.12024.
- Uto T., Uto K., Teno S., Isono K., Omori Y. A case of fulminant type 1 diabetes mellitus detected after cardiac arrest due to diabetic ketoacidosis. J Japan Diab Soc. 2002; 45(9): 689–93. doi: 10.11213/tonyobyo1958.45.689.
- Shimizu I., Makino H., Imagawa A., Iwahashi H., Uchigata Y., Kanatsuka A., Clinical and Immunogenetic Characteristics of Fulminant Type 1 Diabetes Associated With Pregnancy. J Clin Endocrinol Metab. 2006; 91(2): 471-6. doi: 10.1210/jc.2005-1943.
补充文件
